 Adverse impact fibrin clot inhibitors intravesical bacillus Calmette-Guerin therapy superficial bladder tumors intravesical bacillus Calmette-Guerin therapy efficacious treatment prophylaxis tumor recurrence superficial bladder tumors mechanism action Previous work bacillus Calmette-Guerin organisms matrix protein fibronectin fibrin clot formation sites urothelial disruption attachment antitumor effect bacillus Calmette-Guerin Furthermore drugs clot formation antitumor effect intravesical bacillus Calmette-Guerin therapy murine bladder tumor model effect inhibitors fibrin clot formation results intravesical bacillus Calmette-Guerin therapy retrospective analysis evaluable patients intravesical bacillus Calmette-Guerin superficial bladder tumors over-all response rate free tumor patients inhibitors fibrin clot formation bacillus Calmette-Guerin therapy patients medications chi-square striking difference patients recurrent superficial disease patients fibrin clot inhibitors intravesical bacillus Calmette-Guerin therapy recurrent superficial tumors drugs mean followup months chi-square study inhibitors fibrin clot formation adverse influence results intravesical bacillus Calmette-Guerin therapy superficial bladder tumors